Evidence map›Paper›PMID 24857700›Full record

ReviewLancet (London, England)2014

London 2012 Olympic and Paralympic Games: public health surveillance and epidemiology.

Brian McCloskey, Tina Endericks, Mike Catchpole, Maria Zambon, Jim McLauchlin, Nandini Shetty, Rohini Manuel, Deborah Turbitt, Gillian Smith, Paul Crook and 11 more

Abstract readReview
In one paragraph

Review in Lancet (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Pathogen prioritisation for wastewater surveillance ahead of the Paris 2024 Olympic and Paralympic Games, France.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Brian McCloskeyGlobal Center for Mass Gathering Medicine, Riyadh, Saudi Arabia; Global Health and WHO Collaborating Centre on Mass Gatherings, London, UK. Electronic address: Brian.McCloskey@phe.gov.uk.
Tina EndericksGlobal Health and WHO Collaborating Centre on Mass Gatherings, London, UK.
Mike CatchpoleCentre for Infectious Disease Surveillance and Control, London, UK.
Maria ZambonReference Microbiology, London, UK.
Jim McLauchlinFood, Water, and Environmental Microbiology Services, London, UK.
Nandini ShettyPublic Health England, London, UK.
Rohini ManuelPublic Health England, London, UK.
Deborah TurbittPublic Health England, London, UK.
Gillian SmithReal-time Syndromic Surveillance Team, London, UK.
Paul CrookField Epidemiology Services, London, UK.
Ettore SeveriEuropean Programme for Intervention Epidemiology Training, London, UK.
Jane JonesTravel and Migrant Health Section, London, UK.
Sue IbbotsonPHE Centre West Midlands, London, UK.
Roberta MarshallNorth East PHE Centre, London, UK.
Catherine A H SmallwoodGlobal Capacities, Alert and Response, WHO, Geneva, Switzerland.
Nicolas IslaGlobal Preparedness, Surveillance and and Response, WHO, Geneva, Switzerland.
Ziad A MemishGlobal Center for Mass Gathering Medicine, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; Al-Faisal University, Riyadh, Saudi Arabia.
Abdullah A Al-RabeeahGlobal Center for Mass Gathering Medicine, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia.
Maurizio BarbeschiGlobal Center for Mass Gathering Medicine, Riyadh, Saudi Arabia; Global Capacities, Alert and Response, WHO, Geneva, Switzerland.
David L HeymannGlobal Center for Mass Gathering Medicine, Riyadh, Saudi Arabia; Public Health England, London, UK; Royal Institute of International Affairs, Chatham House, London, UK; London School of Hygiene and Tropical Medicine, London, UK.
Alimuddin ZumlaGlobal Center for Mass Gathering Medicine, Riyadh, Saudi Arabia; Division of Infection and Immunity, University College London, London, UK; University College London Hospitals NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mass gatherings are regarded as potential risks for transmission of infectious diseases, and might compromise the health system of countries in which they are hosted. The evidence for increased transmission of infectious diseases at international sporting mass gatherings that attract many visitors from all over the world is not clear, and the evidence base for public health surveillance, epidemiology, and response at events such as the Olympics is small. However, infectious diseases are a recognised risk, and public health planning is, and should remain, a crucial part of the overall planning of sporting events. In this Series paper, we set out the planning and the surveillance systems that were used to monitor public health risks during the London 2012 Olympic and Paralympic Games in the summer of 2012, and draw attention to the public health issues-infectious diseases and chemical, radiation, and environmental hazards-that arose. Although the absolute risk of health-protection problems, including infectious diseases, at sporting mass gatherings is small, the need for reassurance of the absence of problems is higher than has previously been considered; this could challenge conventional public health surveillance systems. Recognition of the limitations of health-surveillance systems needs to be part of the planning for future sporting events.

Indexed as

SportsCommunicable Disease ControlCommunicable DiseasesCrowdingHealth PlanningHumansLondonPublic Health SurveillanceSyndromeTravel

Identifiers

PMID24857700
PMCPMC7138022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.